Morphine, morphine-3-glucuronide, morphine-6-glucuronide, and 6- monoacetylmorphine determined by means of atmospheric pressure chemical ionization-mass spectrometry-liquid chromatography in body fluids of heroin victims

Journal of Analytical Toxicology

Volumn 21, Issue 5, 1997, Pages 346-355

  Bogusz, Maciej J ^a   Maier, Rolf Dieter ^a   Driessen, Sarah ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 ACETATE; MORPHINE 6 GLUCURONIDE;

ADULT; ARTICLE; AUTOPSY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DETERMINATION; FEMALE; HEROIN DEPENDENCE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; VITREOUS BODY;

EID: 0030775582     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/21.5.346     Document Type: Article

References (46)

1. S.Y. Yeh, R.L. McQuinn, and C.W. Corodetzky. Identification of diacetylmorphine metabolites in humans. J. Pharm. Sci. 66: 201-204 (1977).
2. C.E. Inturrisi, B.M. Mitchell, K.M. Foley, M. Schultz, S.U. Shin, and R.W. Houde. The pharmacokinetics of heroin in patients with chronic pain. N. Engl. J. Med. 310: 1213-17 (1984).
3. K. Shimomura, O. Kamata, S. Ueki, S. Ida, K. Oguri, H. Yoshimura, and H. Tsukamoto. Analgesic effect of morphine glucuronides. Tokohu J. Exp. Med. 105: 45-52 (1971).
4. H. Yoshimura, S. Ida, K. Oguri, and H. Tsukamoto. Biochemical basis for analgesic activity of morphine-6β-glucuronide: penetration of morphine-6-glucuronide in the brain of rats. Biochem. Pharmacol. 22: 1423-30 (1973).
5. C.B. Christensen and L.N. Jorgensen. Morphine-6-glucuronide has high affinity for the opioid receptor. Pharmacol. Toxicol. 60: 75-76 (1987).
6. G.W. Pasternak, R.J. Bodnar, J.A. Clark, and C.E. Inturrisi. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 41: 2845-49 (1987).
7. D. Paul, K.M. Standifer, C.E. Inturrisi, and G.W. Pasternak. Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251: 477-83 (1989).
8. R.J. Osborne, S.P. Joel, D. Trew, and M.L. Slevin. Analgesic activity of morphine-6-glucuronide. Lancet i: 828 (1988).
9. J.O. Svensson, A. Rane, J. Säwe, and F. Sjöqvist. Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. J. Chromatogr. 230: 427-32 (1982).
10. J.O. Svensson. Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high-performance liquid chromatography and electrochemical detection. J. Chromatogr. 375: 174-78 (1986).
11. S.P. Joel, R.J. Osborne, and M.L. Slevin. An improved method for the determination of morphine and its principal glucuronide metabolites. J. Chromatogr. 430: 394-99 (1988).
12. P.A. Glare, T.D. Walsh, and C.E. Pippenger. A simple, rapid method for the simultaneous determination of morphine and its principal metabolites in plasma using high-performance liquid chromatography and fluorometric detection. Ther. Drug Monit. 13: 226-32 (1991).
13. Y. Rothsteyn and B. Weingarten. A highly sensitive assay for the simultaneous determination of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma by high-performance liquid chromatography with electrochemical and fluorescence detection. Ther. Drug Monit. 18: 179-88 (1996).
14. R.J. Osborne, S.P. Joel, and M.L. Slevin. Morphine intoxication in renal failure: the role of morphine-6-glucuronide. Brit. Med. J. 292: 1548-49 (1986).
15. G.W. Hanks, P.J. Hoskins, G.W. Aherne, P. Turner, and P. Poulain. Explanation for potency of repeated oral doses of morphine? Lancet ii: 723-24 (1987).
16. E. Bodd, D. Jacobsen, E. Lund, A. Ripel, J. Morland, and E. Wiik-Larsen. Morphine-6-glucuronide might mediate the prolonged opioid effect of morphine in acute renal failure. Hum. Exp. Toxicol. 9: 317-21 (1990).
17. J. Gutierrez-Cebollada, J. Cami, and R. de la Torre. Heroin intoxication: the relation between plasma morphine concentration and clinical state at admission. Eur. J. Clin. Pharmacol. 40: 635 (1991).
18. M.T. Smith, J.A. Watt, and T. Cramond. Morphine-3-glucuronide -a potent antagonist of morphine analgesia. Life Sci. 47: 579-85 (1990).
19. M. Ekblom, M. Gardmark, and M. Hammarlund-Udenaes. Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine. Biopharm. Drug Disp. 14: 1-11 (1993).
20. N. Suzuki, E. Kalso, and P.H. Roseberg. Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats. Eur. J. Pharmacol. 249: 247-50 (1993).
21. A.W. Lipkowski, D.B. Carr, A. Langlade, P.F. Osgood, and S.K. Szyfelbein. Morphine-3-glucuronide: silent regulator of morphine actions. Life Sci. 55: 149-54 (1994).
22. D. Bowsher. Paradoxical pain. When the metabolites of morphine are in the wrong ratio. Brit. Med. J. 306: 473-74 (1993).
23. R. Aderjan, S. Hofmann, G. Schmitt, and G. Skopp. Morphine and morphine glucuronides in serum of heroin consumers and in heroin-related deaths determined by HPLC with native fluorescence detection. J. Anal. Toxicol. 19: 163-68 (1995).
24. M. Bogusz. Concentrations of morphine and its glucuronides among fatally poisoned heroin addicts and patients during oral morphine therapy. Proceedings of the 1994 Joint TIAFT/SOFT Meeting. V. Spiehler, Ed. Newport Beach, CA, 1995. pp 1-11.
25. J. Gerostamoulos and O.H. Drummer. Solid phase extraction of morphine and its metabolites from postmortem blood. Forensic Sci. Int. 77: 53-63 (1995).
26. R. Pacifici, S. Pichini, I. Altieri, A. Caronna, A.R. Passa, and P. Zuccaro. High-performance liquid chromatographic-electrospray mass spectrometric determination of morphine and its 3-and 6-glucuronides: application to pharmacokinetic studies. J. Chromatogr. B 664: 329-34 (1995).
27. N. Tyrefors, B. Hyllbrant, L. Ekman, M. Johansson, and B. Langström. Determination of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human serum by solid-phase extraction and liquid chromatography - mass spectrometry with electrospray ionisation. J. Chromatogr. 729: 279-85 (1996).
28. 6-monoacetylmorphine in urine samples by GC/MS as evidence for heroin use. J. Anal. Toxicol. 9: 134-38 (1985).
29. B.D. Paul, J.M. Mitchell, L.D. Mell, and J. Irving. Gas chromatography/electron impact mass fragmentographic determination of urinary 6-acetylmorphine, a metabolite of heroin. J. Anal. Toxicol. 13: 2-7 (1989).
30. D.C. Fuller and W.H. Anderson. A simplified procedure for the determination of free codeine, free morphine, and 6-acetylmorphine in urine. J. Anal. Toxicol. 16: 315-19 (1992).
31. B.A. Goldberger, E.J. Cone, T.M. Grant, Y.H. Caplan, B.S. Levine, and J.E. Smialek. Disposition of heroin and its metabolites in heroin-related deaths. J. Anal. Toxicol. 18: 22-28 (1994).
32. V.R. Spiehler. Computer-assisted interpretation in forensic toxicology: morphine-involved deaths. J. Forensic Sci. 34: 1104-15 (1989).
33. R. Osborne, S. Joel, D. Trew, and M. Slevin. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the active metabolite morphine-6-glucuronide. Clin. Pharmacol. Ther. 47: 12-19 (1990).
34. A.A. Somogyi. R.L. Nation, C. Olweny, P. Tsirgiotis, J. van Crugten, R.W. Milne, J.F. Cleary, C. Danz, and F. Bochner. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine. Clin. Pharmacokinet. 24: 413-20 (1993).
35. C.R. Goucke, L.P. Hackett, and K.F. Ilett. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain. Pain 56: 145-49 (1994).
36. C.C. Faura, A. Moore, J.F. Horga, C.W. Hand, and H.J. McQuay. Morphine and morphine-6-glucuronide plasma concentrations and effects in cancer pain. J. Pain Symptom Manage. 11: 95-102 (1996).
37. C.W. Hand, W.P. Blunnie, L.P. Claffey, A.J. McShane, H.J. McQuay, and R.A. Moore. Potential analgesis contribution from morphine-6-glucuronide in CSF. Lancet ii: 1207-1208 (1987).
38. G.W. Hanks, P.J. Hoskins, G.W. Aherne, D. Chapman, P. Turner, and P. Poulain. Enterohepatic circulation of morphine. Lancet i: 469 (1988).
39. R.K. Portenoy, E. Khan, M. Layman, J. Lapin, M.G. Malkin, K.M. Foley, H.T. Thaler, D.J. Cerbone, and C.E. Inturrisi. Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations. Neurology 41: 1457-61 (1991).
40. F. Stain, M.J. Barjavel, P. Sandouk. M. Plotkine, J.-M. Scherrmann, and H.N. Bhargava. Analgetic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6 β d-glucuronide in the rat. J. Pharmacol. Exp. Ther. 274: 852-57 (1995).
41. L.J. Murphey and G.D. Olsen. Diffusion of morphine-6-β-D-glucuronide into the neonatal guinea pig brain during drug-induced respiratory depression. J. Pharmacol. Exp. Ther. 271: 118-24 (1994).
42. B.K. Logan and R. Lüthi. The significance of morphine concentrations in the cerebrospinal fluid in morphine caused deaths. J. Forensic Sci. 39: 699-706 (1994).
43. B.K. Logan and D. Smirnow. Postmortem distribution and redistribution of morphine in man. J. Forensic Sci. 41: 37-46 (1996).
44. M.R. Moeller and C. Mueller. The detection of 6-monoacetylmorphine in urine, serum and hair by GC/MS and RIA. Forensic Sci. Int. 70: 125-33 (1995).
45. J. Schuberth and J. Schuberth. Gas chromatographic - mass spectrometric determination of morphine, codeine and 6-monoacetylmorphine in blood extracted by solid phase. J. Chromatogr. 490. 444-49 (1989).
46. B.P. Joynt and N.Z. Mikhael. Sudden death of a heroin body packer. J. Anal. Toxicol. 9: 238-40 (1985).